1563-0625

Medical Immunology (Russia)

SPb RAACI

View prefix report (10.15789)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1365 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1365 DOIs
2

Add abstracts to 967 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact967 DOIs
3

Deposit reference lists for 929 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact929 DOIs

DOIs for this ISSN

Showing the top 5 of 1828 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 APPLICATION OF SIX-COLOR FLOW CYTOMETRIC ANALYSIS FOR IMMUNE… (10.15789/1563-0625-2015-1-19-26)
Abstract References ORCID License
154.41 34
2 Methods (10.15789/1563-0625-2012-3-255-268)
Abstract References ORCID License
153.15 33
3 IMMUNOLOGICAL AND PATHOPHYSIOLOGICAL MECHANISMS OF SYSTEMIC… (10.15789/1563-0625-2012-1-2-9-20)
Abstract References ORCID License
143.14 26
4 BASIC SURFACE MARKERS OF FUNCTIONAL ACTIVITY T-LYMPHOCYTES (10.15789/1563-0625-2014-1-7-26)
Abstract References ORCID License
136.17 22
5 PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56b… (10.15789/1563-0625-2017-1-19-26)
Abstract References ORCID License
136.17 22
6 INFLUENCE OF PROBIOTICS ON CYTOKINE PRODUCTION IN THE IN VIT… (10.15789/1563-0625-2015-5-443-454)
Abstract References ORCID License
132.22 20
7 MECHANISMS OF VITAMIN D ACTION ON THE IMMUNE SYSTEM (10.15789/1563-0625-2014-6-499-530)
Abstract References ORCID License
123.04 16
8 IMMUNE EPITOPE CONTINUUM OF THE PROTEIN RELATIONSHIPS, POLY-… (10.15789/1563-0625-2015-4-335-346)
Abstract References ORCID License
123.04 16
9 MAJOR AND LYMPHOCYTE POPULATIONS OF HUMAN PERIPHERAL BLOOD L… (10.15789/1563-0625-2009-2-3-227-238)
Abstract References ORCID License
120.41 15
10 CHARACTERISTICS AND ROLE OF MACROPHAGES IN PATHOGENESIS OF A… (10.15789/1563-0625-2017-6-657-672)
Abstract References ORCID License
120.41 15
11 APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEM… (10.15789/1563-0625-2018-3-303-312)
Abstract References ORCID License
120.41 15
12 PATHOGENETIC SIGNIFICANCE OF LYMPHOCYTE-TO-PLATELET ADHERENC… (10.15789/1563-0625-2006-5-6-745-753)
Abstract References ORCID License
117.61 14
13 MODERN TECHNOLOGIES AND APPROACHES TO APOPTOSIS STUDIES IN E… (10.15789/1563-0625-2012-6-461-482)
Abstract References ORCID License
117.61 14
14 IMMUNOLOGICAL MECHANISMS OF LOCAL INFLAMMATION (10.15789/1563-0625-2011-6-557-568)
Abstract References ORCID License
114.61 13
15 IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS (10.15789/1563-0625-2014-2-127-138)
Abstract References ORCID License
114.61 13
16 IL–18 AND IMMUNITY (10.15789/1563-0625-2005-4-355-364)
Abstract References ORCID License
111.39 12
17 IMMUNOGLOBULIN A (IgA) AND ITS RECEPTORS (10.15789/1563-0625-2006-4-483-500)
Abstract References ORCID License
111.39 12
18 FREE EXTRACELLULAR DNA IN NORMAL STATE AND UNDER PATHOLOGICA… (10.15789/1563-0625-2013-5-399-412)
Abstract References ORCID License
111.39 12
19 CLINICAL SIGNIFICANCE OF Toll2, Toll4, CD14, AND HLA-DR EXPR… (10.15789/1563-0625-2015-3-221-228)
Abstract References ORCID License
111.39 12
20 MULTICOLOR FLOW CYTOMETRIC ANALYSIS OF CYTOTOXIC T CELL SUBS… (10.15789/1563-0625-2015-6-525-538)
Abstract References ORCID License
111.39 12
21 CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF MURAMYL DIPEPTIDE I… (10.15789/1563-0625-2016-1-15-20)
Abstract References ORCID License
111.39 12
22 PROTECTIVE ACTIVITY STUDY OF A CANDIDATE VACCINE AGAINST ROT… (10.15789/1563-0625-2016-5-417-424)
Abstract References ORCID License
111.39 12
23 PHENOTYPIC CHARACTERISATION OF PERIPHERAL BLOOD CYTOTOXIC T… (10.15789/1563-0625-2018-2-227-240)
Abstract References ORCID License
111.39 12
24 DEVELOPMENT OF REAL-TIME MULTIPLEX PCR FOR THE QUANTITATIVE… (10.15789/1563-0625-2015-5-467-478)
Abstract References ORCID License
107.92 11
25 REGULATORY T–CELLS: ORIGIN AND FUNCTION (10.15789/1563-0625-2005-4-347-354)
Abstract References ORCID License
104.14 10
26 FEATURES OF LUMINOL- AND LUCIGENIN-INDUCED CHEMILUMINESCENCE… (10.15789/1563-0625-2010-4-5-437-440)
Abstract References ORCID License
104.14 10
27 MONOCYTES SUBPOPULATIONS AND CHEMILUMINESCENT ACTIVITY IN PA… (10.15789/1563-0625-2015-2-141-150)
Abstract References ORCID License
104.14 10
28 CLINICO-PATHOGENETIC VALUE OF SOME CYTOKINES IN PERIODONTITI… (10.15789/1563-0625-2017-6-803-806)
Abstract References ORCID License
104.14 10
29 CLINICAL CHARACTERIZATION OF FUNCTIONAL DISORDERS AFFECTING… (10.15789/1563-0625-2013-1-45-50)
Abstract References ORCID License
100.00 9
30 MOLECULAR AND CELLULAR MECHANISMS MEDIATED BY DENDRITIC CELL… (10.15789/1563-0625-2017-4-359-374)
Abstract References ORCID License
100.00 9
31 IMMUNOLOGICAL MARKERS OF UNCONTROLLED ATOPIC BRONCHIAL ASTHM… (10.15789/1563-0625-2017-4-453-460)
Abstract References ORCID License
100.00 9
32 THE ROLE OF INNATE IMMUNITY FACTORS IN TUMORIGENESIS PROCESS (10.15789/1563-0625-2018-2-151-162)
Abstract References ORCID License
100.00 9
33 ANALYSIS OF INITIAL CLINICAL FEATURES OF PRIMARY IMMUNODEFIC… (10.15789/1563-0625-2014-4-367-374)
Abstract References ORCID License
95.42 8
34 DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHE… (10.15789/1563-0625-2015-3-235-244)
Abstract References ORCID License
95.42 8
35 IMMUNOTHERAPY EFFICIENCY IN RHINOSINUSITIS PATIENTS (10.15789/1563-0625-2015-5-423-430)
Abstract References ORCID License
95.42 8
36 CYTOKINE REGULATION OF RESPIRATORY BURST IN BLOOD NEUTROPHIL… (10.15789/1563-0625-2016-5-475-482)
Abstract References ORCID License
95.42 8
37 CYTOKINE GENES AS GENETIC MARKERS OF CONTROLLED AND UNCONTRO… (10.15789/1563-0625-2017-5-605-614)
Abstract References ORCID License
95.42 8
38 CHARACTERISTICS OF CELLULAR IMMUNE STATUS IN THE PATIENTS WI… (10.15789/1563-0625-2017-6-731-738)
Abstract References ORCID License
95.42 8
39 γδТ-LYMPHOCYTES: GENERAL CHARACTERISTICS, SUBPOPULATION PROF… (10.15789/1563-0625-2009-2-3-115-130)
Abstract References ORCID License
90.31 7
40 IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS (10.15789/1563-0625-2013-1-5-12)
Abstract References ORCID License
90.31 7
41 ROLE OF CYTOKINE PRODUCTION DISORDERS IN GENESIS OF PLACENTA… (10.15789/1563-0625-2014-6-539-550)
Abstract References ORCID License
90.31 7
42 CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPO… (10.15789/1563-0625-2015-5-395-406)
Abstract References ORCID License
90.31 7
43 СHANGES OF Glut1, mTOR AND AMPK1α GENE EXPRESSION IN PANCREA… (10.15789/1563-0625-2016-4-339-346)
Abstract References ORCID License
90.31 7
44 IMMUNOPATHOGENETIC ASPECTS OF ISCHEMIC STROKE (10.15789/1563-0625-2018-1-19-34)
Abstract References ORCID License
90.31 7
45 CYTOKINE REGULATION OF REGENERATIVE PROCESSES IN PANCREATIC… (10.15789/1563-0625-2018-1-35-44)
Abstract References ORCID License
90.31 7
46 PURINERGIC REGULATION OF BASIC PHYSIOLOGICAL AND PATHOLOGICA… (10.15789/1563-0625-2018-4-463-476)
Abstract References ORCID License
90.31 7
47 ACTIVATION OF CELLS FROM HYPOTHALAMIC STRUCTURES AFTER INJEC… (10.15789/1563-0625-2006-5-6-631-636)
Abstract References ORCID License
84.51 6
48 AN IMMUNOTHERAPEUTIC CONCEPT OF MICROBIAL ANTIGEN APPLICATIO… (10.15789/1563-0625-2008-1-13-20)
Abstract References ORCID License
84.51 6
49 CHANGES OF HLA-DR ANTIGEN EXPRESSION ON MONOCYTES IN CHILDRE… (10.15789/1563-0625-2008-4-5-379-388)
Abstract References ORCID License
84.51 6
50 STRUCTURE AND IMMUNE ADJUVANT PROPERTIES OF CPG-D (10.15789/1563-0625-2010-6-469-476)
Abstract References ORCID License
84.51 6